跳至主要内容
临床试验/EUCTR2014-003691-23-NL
EUCTR2014-003691-23-NL进行中(未招募)1 期

Topical Ingenol mebutate versus 5% 5-fluorouracil versus 5% Imiquimod versus photodynamic therapy in the treatment of actinic keratosis: a multi-center randomized efficacy and cost-effectiveness study

Maastricht Universitair Medisch Centrum0 个研究点目标入组 624 人开始时间: 2014年9月30日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
624

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -Patients older than 18 years
  • - Female in child bearing potential should be using contraceptive measures,
  • during and till 3 months post-treatment
  • -Fitzpatrick skintype I-IV
  • -Clinically confirmed diagnosis of AK
  • -One joint area of minimal 25 cm2 and maximal 100 cm2 of AK
  • -AK Olsen grade I-III
  • -Location: head/neck area
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 312
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 312

排除标准

  • -Received any kind of treatment for AK in the past 3 months
  • -(N)MSC in target area
  • -Immuno-comprised status
  • -Use of immunosuppressant drugs in the past 3 months and / or at time of
  • treatment (inhalation corticosteroids / nasal corticosteroids are permitted)
  • -Porphyria
  • -Not able to give informed consent
  • -Allergy to study drugs or nut/soy products
  • -Pregnant and breastfeeding women
  • -Genetic skin cancer disorders
  • - No understanding of dutch language

研究者

发起方
Maastricht Universitair Medisch Centrum

相似试验